Showing results (3991-4000 of 4,889) with videos related to

Sort By:
Pageof 489
Science Translational Medicine|August 26, 2021
Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell αB-crystallinRebecca Herzog, Juan Manuel Sacnun, Guadalupe González-Mateo, et al.
Science Translational Medicine|August 12, 2021
The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid β fibril formationMaría Pagnon de la Vega, Vilmantas Giedraitis, Wojciech Michno, et al.
Science Translational Medicine|May 29, 2020
Ethical and societal implications of cellular health-monitoring devicesAnna Deplazes-Zemp, Martin Fussenegger, Nikola Biller-Andorno
Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.
Science Translational Medicine|May 13, 2021
Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxideBrock J Sishc, Lianghao Ding, Taek-Keun Nam, et al.
Science Translational Medicine|May 13, 2021
A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibilityAlexander Y Trick, Johan H Melendez, Fan-En Chen, et al.
Science Translational Medicine|May 13, 2021
Response to comment on "Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI"Xiaowen Yu, Yue Zhang, Zhanjun Jia, et al.
Science Translational Medicine|May 20, 2021
Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repairKatie J Mylonas, Eoin D O'Sullivan, Duncan Humphries, et al.
Science Translational Medicine|May 20, 2021
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancerChristopher S Garris, Jeffrey L Wong, Jeffrey V Ravetch, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 489